Skip to main content
. 2000 Nov;7(6):872–881. doi: 10.1128/cdli.7.6.872-881.2000

TABLE 3.

Test results of HIV-1 seroconversion serum panels by various methods (panels 8, 9, and 10)

HIV-1 seroconversion serum panel no. Days after initial blood collection Cutoff indexes
Maximal dilution to cause gelatin particle agglutination Western blot
p24 antigen by previous immunoassay p24 antigen by improved immunoassay RNA Anti-p17 IgG by previous immunoassay Anti-p17 IgG by improved immunoassay Anti-p17 IgM Anti-HIV-1 antibodies by conventional EIA gp160 gp120 gp41 p24 p17
8 (SV-0031) 0 0.2 0.3 0.2 0.3 0.4 0.2
4 0.1 0.3 0.1 0.6 0.4 0.2
7 0.1 0.2 0.1 0.9 0.7 0.3
12 0.2 0.3 0.1 0.4 0.5 0.2
19 0.1 0.3 0.0 0.6 0.4 0.4
26 0.2 0.6 0.4 1.2 1.0 0.3
28 0.3 0.5 0.3 0.3 0.7 0.3
46 201 5,374 2.0 48 0.8 4.2 4
48 255 6,807 1.4 16 0.9 5.1 8
53 324 6,580 57 4,103 470 2.9 32
55 208 5,471 262 1,662 1.9 32
60 30 1,092 2,163 3,871 2.5 16 +
62 18 595 3,732 4,767 2.8 16 +
67 16 441 6,789 4,304 3.7 32 + + +
9 (panel E) 0 0.3 0.3 <0.1 0.2 4.7 3.9 0.3
7 0.4 0.2 <0.1 0.6 22 30 0.3
21 0.4 0.2 <0.1 0.3 16 22 0.2
35 0.5 0.3 <0.1 0.4 3.0 2.3 0.3
42 0.5 0.3 <0.1 0.4 2.0 1.0 0.3
49 0.5 0.3 <0.1 0.7 1.7 0.8 0.2
63 0.5 0.2 <0.1 0.4 1.6 0.6 0.2
84 25 677 0.8 0.6 1.4 0.5 0.2
91 8,092 8,707 825 0.4 1.4 0.8 0.8
126 14 45 2.8 9,786 445,068 11,078 4.6 32 + + +
10 (SV-0241) 0 0.7 29 108 0.5 21 0.4 0.2
6 77 5,754 7,500 0.8 23 0.3 0.2
8 31 2,358 2,500 0.3 5.9 0.4 0.3
14 3.1 154 300 42 2,249 164 7.4 8 + +
16 1.6 48 88 433 712 6.0 16 + +
21 1.2 1.8 9.8 3,554 2,966 5.6 16 + +
23 0.7 0.7 3.8 5,454 3,062 4.2 16 + +